Biocon raises Rs 2,250 crore through Commercial Papers

24 Nov 2022 Evaluate

Biocon has raised Rs 2,250 crore through Commercial Papers (CP) on private placement basis on November 23, 2022. Date of maturity of said Commercial Papers will be February 22, 2023. The company had received approval from board of directors on November 14, 2022 for the same.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

316.15 -4.65 (-1.45%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.